JNM Global

Global Approval Partner

certification 31

China NMPA, Announcement of No. 84 [2024] to clarify requirements for high frequency treatment devices

The National Medical Products Administration (NMPA) of China issued the Regulations on July 8, 2024 to steadily promote the relevant work of high-frequency treatment devices and high-frequency skin treatment devices, and take into account the requirements of public equipment safety and orderly development of the industry. Annex 09-07-02 of the “Notice on Partial Adjustment of the Medical Device ..

China NMPA, Guidelines for Registration and Review of radio frequency beauty devices

The CMDE under the National Medical Products Administration (NMPA) of China has issued guidelines for registration and review of high-frequency beauty devices (No. 8[2023]). Manufacturers of radio frequency beauty devices classified as Class III will have to comply with the new technical review guidelines from April 1, 2024. The High Frequency beauty device Registration and Review Guidelines (No..

Korea, List of medical device certification and approval support projects conducted in 2023

Medical device companies have many difficulties entering the market due to the cost and time required to obtain certification, the creation of enhanced technical documents, and the lack of information on essential regulations by country. Various organizations are carrying out many support projects to solve these difficulties, minimize the burden of certification barriers, and help them enter the..

European Commission Decides to Ease UDI Requirements for Contact Lenses

The European Medical Device Regulations (Regulation 2017/745, MDR) require that each particular device model has its own UDI-DI. Contact lenses vary widely, requiring the manufacturer to specify a number of UDI-DI. The EC adopted this mandate out of concern that a higher number of UDI-DI would lead to a surge in medical device registrations in EUDAMED. The amendment takes effect on November 9, 2..

Mexico in vitro diagnostic medical device Cofepris certificate

Medical devices and in vitro diagnostic medical devices in Mexico comply with the Mexico standard NOM-241-SSA1-2021. Mexico is classified into Class I, Class II, and Class III depending on risk, and all medical devices and in vitro diagnostic medical devices must be registered mandatory sanitary registration. The regulatory authorities related to medical devices and in vitro diagnostic medical d..

Three new UK Approved Bodies to certify medical devices announced by the MHRA

On August 29, 2023, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced that they had designated three new UK Approved Bodies, almost doubling the UK’s current capacity to certify medical devices. Under the current UK legislation, before a manufacturer can place a UKCA-marked medical device on the market in England, Wales and Scotland, they must secure UKCA marking from a UK..

FDA Issues Draft Guidance for Registration and Listing of Cosmetic Product Facilities and Products

The VCRP program has been suspended since March this year under the Modernization of Cosmetics Regulation Act of 2022. On August 7, 2023, the FDA issues draft guidance for registration and listing of cosmetic product facilities and product Under MoCRA, submission of information about existing cosmetic product facilities and products is required no later than Dec. 29 and Renewal every two years. ..

JNM Global/Cosmetic 2023.08.23

メキシコ COFEPRISの化粧品登録について

メキシコ化粧品認証を取得するためには、メキシコ保険省の傘下機関である連邦衛生危険管理委員会 (COFEPRIS, Comisión Federal para la Protección contra Riesgos Sanitarios)に下記の通りの手順で申請する必要があります。 1)COFEPRIS 認証を取得するためにはメキシコ現地に所在していることが条件です。海外企業の場合は法的代理人を指定する必要があります。 2)使用禁止成分に該当しているのかどうか、成分の検討を行います。 3)下記のメキシコ公式標準規格 (NOM, Normas Oficiales Mexicanas) から要求するラベリングを満たしているのか検討し、COFEPRISが指定した検証所からラベル承認を受けます。 ー 包装された化粧品のラベリング、衛生及び商業的なラベリング:NOM-141-SSA1/SCFI-..